Retour sur lavenir.net
   UMICORE 22.520 € (+1,99 %)     ARGENX SE 813.000 € (+2,14 %)     CENERGY 25.000 € (-5,87 %)     LOTUS BAKERIES 11 060.000 € (-0,18 %)     SYENSQO 65.300 € (-1,58 %)     AGEAS 68.900 € (+0,07 %)     KINEPOLIS GROUP 35.500 € (+0,42 %)     KBC ANCORA 83.000 € (0,00 %)     ACKERMANS V.HAAREN 287.800 € (-0,83 %)     GIMV 44.800 € (+0,79 %)     BARCO 8.475 € (-1,45 %)     MELEXIS 81.250 € (-4,41 %)     OXURION 0.003 € (-5,88 %)     COFINIMMO 80.600 € (-0,49 %)     CMB.TECH 13.860 € (+5,00 %)     INCLUSIO SA/NV 16.600 € (-1,19 %)     BPOST 1.578 € (0,00 %)     ACCENTIS 0.027 € (0,00 %)     ECONOCOM GROUP 1.530 € (-1,29 %)     COLRUYT 34.380 € (+0,53 %)     WHAT'S COOKING GP 145.000 € (0,00 %)     IMMOBEL 22.200 € (-5,13 %)     ONTEX GROUP 2.415 € (+0,21 %)     AGFA-GEVAERT 0.432 € (-0,58 %)     BREDERODE 102.000 € (-1,16 %)     QRF 11.150 € (-0,45 %)     BIOTALYS 3.155 € (-1,10 %)     SOLVAY 27.100 € (-1,38 %)     FAGRON 24.050 € (-0,41 %)     NYXOAH 1.434 € (+1,56 %)     ONWARD MEDICAL 2.680 € (+1,52 %)     CARE PROPERTY INV. 12.520 € (+0,32 %)     DECEUNINCK 2.220 € (-3,48 %)     BANQUP GROUP 2.320 € (-2,52 %)     IBA 16.100 € (-0,98 %)     HOME INVEST BE. 19.100 € (-1,44 %)     XIOR 26.000 € (-0,57 %)     RETAIL ESTATES 69.500 € (0,00 %)     MATERIALISE 5.750 € (0,00 %)     FLUXYS BELGIUM D 20.400 € (+3,03 %)     TUBIZE-FIN 215.400 € (+0,37 %)     VASTNED 29.450 € (-0,84 %)     UCB 251.700 € (+1,66 %)     VAN DE VELDE 30.200 € (+0,33 %)     DEME GROUP 181.800 € (-0,98 %)     JENSEN-GROUP 82.000 € (-3,98 %)     TINC 11.680 € (0,00 %)     CIE BOIS SAUVAGE 296.000 € (-1,00 %)     TESSENDERLO 19.880 € (-1,58 %)     AEDIFICA 68.550 € (-0,44 %)     VGP 80.100 € (-1,84 %)     AZELIS GROUP 9.585 € (-2,09 %)     AB INBEV 72.200 € (+1,92 %)     EVS 28.200 € (0,00 %)     ELIA GROUP 135.600 € (-0,29 %)     GBL 78.800 € (-0,94 %)     SOFINA 220.200 € (-2,74 %)     CAMPINE 224.000 € (-1,75 %)     TITAN S.A. 53.050 € (-1,21 %)     D'IETEREN GROUP 165.900 € (+0,48 %)  
   ADYEN 833.000 € (-4,71 %)     AIR LIQUIDE 166.440 € (+0,45 %)     AEGON 7.550 € (0,00 %)     STMICROELECTRONICS 63.470 € (-8,53 %)     ALSTOM 16.175 € (-0,22 %)     COMPAGNIE ODET 1 490.000 € (-0,13 %)     ING GROEP N.V. 27.915 € (-0,92 %)     IPSEN 162.600 € (+3,44 %)     ARKEMA 57.200 € (-1,21 %)     LINEDATA SERVICES 40.500 € (-2,41 %)     L'OREAL 376.000 € (-0,56 %)     TOTALENERGIES 70.810 € (-0,16 %)     ASML HOLDING 1 560.800 € (-5,74 %)     ORANGE 16.905 € (+0,24 %)     STELLANTIS NV 5.273 € (-6,66 %)     LVMH 483.700 € (+0,49 %)     CRCAM BRIE PIC2CCI 36.690 € (-0,05 %)     THALES 228.000 € (+0,75 %)     KEYRUS 8.140 € (+9,70 %)     RELX 27.260 € (+0,81 %)     REXEL 37.130 € (-3,26 %)     GENFIT 11.020 € (+2,80 %)     TOUR EIFFEL 8.120 € (-0,25 %)     BOLLORE 4.010 € (+2,82 %)     EXOR NV 64.700 € (-2,27 %)     HEINEKEN 72.560 € (+2,20 %)     VALLOUREC 22.230 € (-0,18 %)     THX PHARMA 3.320 € (+0,91 %)     HAL TRUST 164.000 € (-0,24 %)     SCHNEIDER ELECTRIC 279.500 € (-4,53 %)     AHOLD DEL 34.850 € (+1,81 %)     SIGNIFY NV 17.830 € (-14,77 %)     QUADIENT 12.140 € (+0,50 %)     EXAIL TECHNOLOGIES 102.800 € (-1,15 %)     PROSUS 36.955 € (-2,38 %)     ACOMO 22.700 € (+0,44 %)     VINCI 129.100 € (-1,19 %)     ASM INTERNATIONAL 994.000 € (-7,88 %)     KPN KON 4.373 € (+0,28 %)     CEGEDIM 11.400 € (-0,87 %)     DASSAULT AVIATION 296.600 € (+1,23 %)     ESSILORLUXOTTICA 168.150 € (-0,21 %)     CRCAM NORD CCI 29.990 € (-0,43 %)     SOLUTIONS 30 SE 0.667 € (-0,74 %)     INPOST 15.350 € (-0,13 %)     BOUYGUES 50.020 € (-0,79 %)     SOITEC 120.400 € (-6,99 %)     SAFRAN 331.100 € (-0,03 %)     BAM GROEP KON 12.340 € (-0,88 %)     ARCELORMITTAL SA 55.840 € (+0,61 %)     APERAM 46.760 € (-0,13 %)     MICHELIN 32.670 € (-2,10 %)     PHILIPS KON 23.410 € (-1,14 %)     BUREAU VERITAS 25.740 € (+0,78 %)     ADP 110.200 € (-0,90 %)     2CRSI 27.620 € (+25,55 %)     CRCAM LANGUED CCI 97.030 € (+0,03 %)     KAUFMAN ET BROAD 24.000 € (-0,83 %)     DERICHEBOURG 10.050 € (+0,60 %)     BNP PARIBAS ACT.A 101.440 € (-0,39 %)  
News Réglementées
22/02/2023 16:30

Cloud DX Launches First Remote Monitoring Program for Type 2 Diabetes Patients

Customer grows its Connected Health™ RPM offerings, adds Cloud DX Diabetes care pathway to its existing Palliative RPM program

News in Summary
• Leading Ontario health organization to launch Diabetes RPM program
• Program aims to achieve a volume of 100 users this year
• RPM is well suited for Diabetes Type 2 Management

KITCHENER, ON / ACCESSWIRE / February 22, 2023 / Cloud DX (TSXV:CDX)(OTC:CDXFF), a leading health data platform, has announced the launch of its first Remote Patient Monitoring (RPM) program for Type 2 Diabetes patients. The customer is a leading Ontario healthcare organization and current Cloud DX client.

The new program aims to introduce Remote Patient Monitoring into the well-established Diabetes Management program at an Ontario family health organization. The program will use existing remote care monitoring (RCM) tools to augment/replace manual data collection activities within the existing patient population. Upon reaching their goal of enrolling 100 patients, the account would generate up to $48,000 CAD per year in recurring revenue.

Using the Cloud DX Connected Health™ platform, this program will deliver a single RPM environment for all healthcare providers. Dedicated diabetes management resources are currently in place at in-scope clinics and will continue to provide guidance and clinical oversight for Type 2 Diabetes patients. The program will support both full Connected Health™ kits and a ‘bring your own device' (BYOD) option. Kits that include cellular tablets are designed to ‘just work' right out of the box, which is a great user experience for older patients - meanwhile younger patients are often comfortable pairing Cloud DX devices with their own phone or tablet. BYOD deployments generally offer higher margins, a Cloud DX focus for 2023.=

Connected Health™ allows for unlimited periodic monitoring of blood sugar levels and provides access to data that can help patients better understand and control their disease. Automated notifications inform individuals and their healthcare providers when blood sugar levels fall outside a specific range, helping them quickly identify and address potential problems. Targeted, customized surveys will allow for easy assessment of patients' symptoms, behaviour patterns and well-being.

Cloud DX COO and co-founder Anthony Kaul says, "Cloud DX's Connected Health™ RPM program for Type 2 Diabetes patients is a significant step forward in providing patients with the tools they need to manage their disease effectively. Connected Health™ will help individuals with type 2 diabetes better understand and control their disease, leading to better blood sugar control, fewer complications, and a better quality of life."

Diabetes patients respond well to virtual care, which is encouraged by the American Diabetes Association. Improved outcomes rely on patient-generated health data (PGHD) and a health-coaching approach to behavior management, both of which can be used at a distance.

Cloud DX Inc., Wednesday, February 22, 2023, Press release picture
About Cloud DX

Cloud DX is on a mission to make healthcare better for everyone. Clinics and hospitals across North America use our Connected Health™ data platform to incorporate remote and virtual technology in care delivery. Our remote monitoring solutions let care teams virtually monitor hundreds of patients; Patients take vital signs at home with intelligent medical devices which transmit the data to the care team's dashboard or EMR. Connected Health™ supports remote vital sign monitoring, behavioral medicine, telehealth, care pathways for chronic care, aging in place, palliative or perioperative hospital-at-home, and more. Our customers achieve better healthcare and patient outcomes, reduce hospitalizations and readmissions, lower care delivery costs, and grow patient panels, revenue, and more.

Cloud DX is an exclusive partner to Medtronic Canada, Teladoc Health Canada, and Equitable Life of Canada. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, 2022 Top Innovator by Canadian Business, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers."

For more information on Cloud DX (TSXV:CDX), visit www.CloudDX.com and follow @CloudDX on Twitter or LinkedIn .

Cloud DX Investor Site https://ir.clouddx.com/overview/default.aspx

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

# # #

Media Contact

Janine Scott
Marketing Lead
888-543-0944
Janine.Scott@CloudDX.com

Investor Relations Contacts

Canada
Jay Bedard
647-881-8418
Jay.Bedard@CloudDX.com

USA
Gary Zwetchkenbaum
516-455-7662
IR@CloudDX.com

Forward Looking Statements

This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans", "expects" or "does not expect ", "is expected ", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. In particular, this news release includes certain forward-looking statements concerning the advancement of the Company's business and partnerships, the expected proceeds therefrom, regulatory approvals, as well as management's objectives, strategies, beliefs and intentions.

SOURCE: Cloud DX Inc.



View source version on accesswire.com:
https://www.accesswire.com/740342/Cloud-DX-Launches-First-Remote-Monitoring-Program-for-Type-2-Diabetes-Patients

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière